NO900032L - Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser.Info
- Publication number
- NO900032L NO900032L NO90900032A NO900032A NO900032L NO 900032 L NO900032 L NO 900032L NO 90900032 A NO90900032 A NO 90900032A NO 900032 A NO900032 A NO 900032A NO 900032 L NO900032 L NO 900032L
- Authority
- NO
- Norway
- Prior art keywords
- tiazol
- compounds
- procedure
- preparation
- therapeutically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB898900191A GB8900191D0 (en) | 1989-01-05 | 1989-01-05 | Thiazole compounds,processes for the preparation thereof and pharmaceutical composition comprising the same |
| GB898906575A GB8906575D0 (en) | 1989-03-22 | 1989-03-22 | Thiazole compounds,processes for the preparation thereof and pharmaceutical compositions comprising the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO900032D0 NO900032D0 (no) | 1990-01-04 |
| NO900032L true NO900032L (no) | 1990-07-06 |
Family
ID=26294803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO90900032A NO900032L (no) | 1989-01-05 | 1990-01-04 | Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0377457A1 (de) |
| JP (1) | JP3003148B2 (de) |
| KR (1) | KR900011765A (de) |
| CN (1) | CN1043936A (de) |
| AU (1) | AU631169B2 (de) |
| CA (1) | CA2007133A1 (de) |
| FI (1) | FI900035A (de) |
| HU (1) | HU205922B (de) |
| IL (1) | IL92939A0 (de) |
| NO (1) | NO900032L (de) |
| PT (1) | PT92786B (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0372125A1 (de) * | 1988-11-08 | 1990-06-13 | Akzo N.V. | Oxazol und Thiazol-Derivate |
| DE69132293D1 (de) * | 1991-03-07 | 2000-08-10 | Hisamitsu Pharmaceutical Co | Diphenylthiazolderivate mit antiinflammatorischer aktivität |
| HUT71097A (en) * | 1992-02-13 | 1995-11-28 | Merrell Dow Pharma | Piperidinyl-heterocyclic derivatives, containing sulphur pharmaceutical compositions comprising them and process for their preparation |
| ES2125285T3 (es) * | 1992-07-31 | 1999-03-01 | Bristol Myers Squibb Co | Derivados inhibidores de la reabsorcion de adenosina de difenil-oxazoles, tiazoles e imidazoles. |
| TWI283577B (en) * | 1999-10-11 | 2007-07-11 | Sod Conseils Rech Applic | Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof |
| US20020183316A1 (en) * | 2000-10-27 | 2002-12-05 | Kevin Pan | Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders |
| AR038966A1 (es) * | 2002-03-18 | 2005-02-02 | Solvay Pharm Bv | Derivados de tiazol que tienen actividad antagonista, agonista o agonista parcial de cb1 |
| GB0216700D0 (en) | 2002-07-18 | 2002-08-28 | Astrazeneca Ab | Process |
| US7074809B2 (en) | 2002-08-09 | 2006-07-11 | Astrazeneca Ab | Compounds |
| BR0313266A (pt) * | 2002-08-09 | 2005-06-21 | Astrazeneca Ab | Compostos, respectivos processos de preparação e uso, formulação farmacêutica e métodos de prevenção e/ou tratamento de um distúrbio mediado pelo receptor de mglur5 e de inibição da ativação de receptores de mglur5 |
| IL166510A0 (en) | 2002-08-09 | 2006-01-15 | Nps Pharma Inc | 1,2,4"oxadiazole as modulators of metabotropic glutamate receptor-5 |
| US20040198800A1 (en) * | 2002-12-19 | 2004-10-07 | Geoffrey Allan | Lipoxygenase inhibitors as hypolipidemic and anti-hypertensive agents |
| GB0230087D0 (en) * | 2002-12-24 | 2003-01-29 | Astrazeneca Ab | Therapeutic agents |
| GB0302673D0 (en) | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
| GB0302672D0 (en) * | 2003-02-06 | 2003-03-12 | Astrazeneca Ab | Pharmaceutical formulations |
| JP2006182648A (ja) * | 2003-04-08 | 2006-07-13 | Dai Ichi Seiyaku Co Ltd | ７員複素環誘導体 |
| WO2004094407A1 (ja) * | 2003-04-21 | 2004-11-04 | Daiichi Pharmaceutical Co. Ltd. | ５員複素環誘導体 |
| TWI336697B (en) * | 2003-09-19 | 2011-02-01 | Solvay Pharm Bv | Thiazole derivatives as cannabinoid receptor modulators |
| MXPA06004434A (es) * | 2003-10-24 | 2006-06-20 | Solvay Pharm Gmbh | Usos medicos novedosos de compuestos que muestran actividad antagonista cb1 y tratamiento de combinacion que involucra tales compuestos. |
| WO2006045799A2 (en) | 2004-10-25 | 2006-05-04 | Solvay Pharmaceuticals Gmbh | Pharmaceutical compositions comprising cb1 cannabinoid receptor antagonists and potassium channel openers for the treatment of diabetes mellitus type i, obesity and related conditions |
| DE102009038123A1 (de) | 2009-08-17 | 2011-02-24 | Aicuris Gmbh & Co. Kg | Substituierte (Thiazolyl-carbonyl)imidazolidinone und ihre Verwendung |
| MA46540A (fr) * | 2016-10-12 | 2019-08-21 | Res Triangle Inst | Agonistes du récepteur de l'apéline (apj) hétérocyclique et leurs utilisations |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1496787A (en) * | 1974-03-12 | 1978-01-05 | Smith Kline French Lab | Heteroalkylthioalkyl amidine derivatives |
| AU539801B2 (en) * | 1980-10-14 | 1984-10-18 | Pfizer Inc. | Intermediates in the preparation of 2-guanidino-4- heteroarylthiazoles |
| DE3413755A1 (de) * | 1984-04-12 | 1985-10-24 | Basf Ag, 6700 Ludwigshafen | Thiazolylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses |
| DE3621775A1 (de) * | 1986-03-13 | 1988-01-07 | Thomae Gmbh Dr K | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
| GB8714789D0 (en) * | 1987-06-24 | 1987-07-29 | Lundbeck & Co As H | Heterocyclic compounds |
-
1989
- 1989-12-29 JP JP1343984A patent/JP3003148B2/ja not_active Expired - Lifetime
- 1989-12-31 IL IL92939A patent/IL92939A0/xx unknown
-
1990
- 1990-01-04 EP EP90100123A patent/EP0377457A1/de not_active Withdrawn
- 1990-01-04 KR KR1019900000035A patent/KR900011765A/ko not_active Application Discontinuation
- 1990-01-04 CN CN90100083A patent/CN1043936A/zh active Pending
- 1990-01-04 FI FI900035A patent/FI900035A/fi not_active Application Discontinuation
- 1990-01-04 HU HU9041A patent/HU205922B/hu not_active IP Right Cessation
- 1990-01-04 CA CA002007133A patent/CA2007133A1/en not_active Abandoned
- 1990-01-04 AU AU47687/90A patent/AU631169B2/en not_active Ceased
- 1990-01-04 NO NO90900032A patent/NO900032L/no unknown
- 1990-01-05 PT PT92786A patent/PT92786B/pt active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| JP3003148B2 (ja) | 2000-01-24 |
| PT92786B (pt) | 1996-01-31 |
| HUT54129A (en) | 1991-01-28 |
| JPH0327370A (ja) | 1991-02-05 |
| NO900032D0 (no) | 1990-01-04 |
| KR900011765A (ko) | 1990-08-02 |
| IL92939A0 (en) | 1990-09-17 |
| AU631169B2 (en) | 1992-11-19 |
| AU4768790A (en) | 1990-07-12 |
| CN1043936A (zh) | 1990-07-18 |
| FI900035A0 (fi) | 1990-01-04 |
| EP0377457A1 (de) | 1990-07-11 |
| HU900041D0 (en) | 1990-03-28 |
| HU205922B (en) | 1992-07-28 |
| CA2007133A1 (en) | 1990-07-05 |
| PT92786A (pt) | 1990-07-31 |
| FI900035A (fi) | 1990-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO871267L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazepinforbindelser. | |
| NO904694D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| NO179584C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-acylaminotiazoler | |
| NO901684L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
| NO872946D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser. | |
| NO175978C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser | |
| NO900032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazol-forbindelser. | |
| NO902411D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-hydroksy-n-propylaminer. | |
| NO864879D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiasolforbindelser. | |
| NO903941D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater. | |
| NO883485L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser. | |
| NO890155D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser. | |
| NO880667L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser. | |
| NO174203C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive | |
| NO873514D0 (no) | Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser. | |
| NO904800L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive karbamater. | |
| NO304428B1 (no) | AnalogifremgangsmÕte for fremstilling av terapeutisk aktive vinylazoler | |
| NO168530C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser. | |
| NO900972D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
| NO882281D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
| NO903397L (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd. | |
| NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
| NO892469D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-forbindelser. | |
| NO883959D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere. | |
| NO882282L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. |